-
公开(公告)号:US20210124977A1
公开(公告)日:2021-04-29
申请号:US17048817
申请日:2019-04-18
Inventor: Karen PANETTA , Shreyas KAMATH KALASA MOHANDAS , Sos AGAIAN
Abstract: The present disclosure includes systems and methods for multimedia image analytic including automated binarization, segmentation, and enhancement using bio-inspired based visual morphology schemes. The present disclosure further includes systems and methods for biometric multimedia content authentication using extracted geometric features and one or more of the binarization, segmentation, and enhancement methods.
-
公开(公告)号:US20210115424A1
公开(公告)日:2021-04-22
申请号:US17052116
申请日:2019-05-01
Applicant: The Regents of the University of California , The Board of Regents of The University of Texas System
Inventor: Robert T. Clubb , Brendan Rayhan Amer , Janine Y. Fu , Scott McConnell , Hung Ton-That , Chungyu Chang
Abstract: Covalently cross-linked pilus polymers displayed on the cell surface of Gram-positive bacteria are assembled by class C sortase enzymes. These pilus-specific transpeptidases located on the bacterial membrane catalyze a two-step protein ligation reaction—first, cleaving the LPXTG motif of one pilin protomer to form an acyl-enzyme intermediate, and second, joining the terminal threonine to the nucleophilic lysine residue residing within the pilin motif of another pilin protomer. Informed by the high-resolution crystal structures of corynebacterial pilus-specific sortase (SrtA) and by developing structural variants of the sortase enzyme whose catalytic pocket has been unmasked by activating mutations, we have developed new reagents capable of forming isopeptide bonds in vitro. The reagents disclosed herein can catalyze ligation of isolated SpaA domains in vitro provide a facile and versatile new platform for protein engineering and bio-conjugation that has major implications for biotechnology.
-
公开(公告)号:US20210113402A1
公开(公告)日:2021-04-22
申请号:US16606627
申请日:2018-04-20
Inventor: Muthu WIJESUNDARA , Wei Carrigan
Abstract: Pressure modulating soft actuator array devices and related systems and methods. One example of the present systems comprises: a device having a body that defines a plurality of cavities; a pressure source configured to be in fluid communication with the plurality of cavities; a plurality of sensors configured to capture data indicative of pressure within the plurality of cavities; and one or more controllers configured to actuate the pressure source to move fluid toward and/or away from one or more of the plurality of cavities in response to data captured by the plurality of sensors; wherein the device is configured to be disposed between a user and a surface on which the user is seated upon.
-
公开(公告)号:US20210090259A1
公开(公告)日:2021-03-25
申请号:US17031010
申请日:2020-09-24
Inventor: Darin T Okuda
Abstract: Some methods of analyzing one or more brain lesions of a patient comprise, for each of the lesion(s), calculating one or more lesion characteristics from a first 3-dimensional (3D) representation of the lesion obtained from data taken at a first time and a second 3D representation of the lesion obtained from data taken at a second time that is after the first time. The characteristic(s) can include a change, form the first time to the second time, in the lesion's volume and/or surface area, the lesion's displacement from the first time to the second time, and/or the lesion's theoretical radius ratio at each of the first and second times. Some methods comprise characterizing whether the patient has multiple sclerosis and/or the progression of multiple sclerosis in the patient based at least in part on the calculation of the lesion characteristic(s) of each of the lesion(s).
-
公开(公告)号:US10953031B2
公开(公告)日:2021-03-23
申请号:US16353737
申请日:2019-03-14
Inventor: William S. Korinek , James D. Lechleiter , Theodore E. Liston
IPC: A61K31/7076 , A61K31/52
Abstract: The present invention relates to compounds and methods of use thereof for treatment of certain disorders and conditions, for example brain injuries such as stroke or traumatic brain injuries.
-
公开(公告)号:US20210079351A1
公开(公告)日:2021-03-18
申请号:US16875142
申请日:2020-05-15
Inventor: Xiao-Dong Chen
IPC: C12N5/077 , C12N5/0775 , C12N5/073 , A61K35/28 , A61K35/34
Abstract: In some aspects, this invention provides a method of making a bone marrow-derived tissue-specific stem cell proliferation, expansion, isolation and rejuvenation extracellular matrix. In other aspects, this invention provides a method of making a tissue-specific fibroblast-derived stem cell differentiation extracellular matrix. Also provided are methods of using such a cell-derived preservation or differentiation matrices to induce tissue-specific differentiation of pluripotent cells, repair damaged tissue, and treat a subject having a physiologic deficiency using the same.
-
公开(公告)号:US20210060310A1
公开(公告)日:2021-03-04
申请号:US17051311
申请日:2019-04-25
Inventor: Daniel H. KIM , Dong Suk SHIN , Viljar PALMRE , Younghee SHIM , Bhavik PATEL
Abstract: A catheter comprises a hollow sheath, a guidewire extendable through the hollow sheath, where the guidewire comprises a controllably bendable tip portion, a hollow tubular intermediate portion connected to the tip portion, an electrical connection portion connected to the hollow tubular portion, at least a first wire extending through the hollow tubular portion and connected at a first end thereof to a first circumferential conductor and at a second end thereof to a surface of the tip end, and a power supply connector, therein the electrical connection portion is received in the power supply connector and a first terminal in the power supply connector contacts the first circumferential conductor.
-
公开(公告)号:US20210045556A1
公开(公告)日:2021-02-18
申请号:US16963240
申请日:2019-01-16
Inventor: Ali Seifi
IPC: A47G21/18
Abstract: The hiccup relieving apparatus includes a tube with a first end having a mouthpiece, a second end for immersion in water or other potable liquid in a container, and an obstruction in the tube between the first end and the second end. The obstruction requires an adult user, using the mouthpiece, to produce a threshold suction of at least 20 cm of water before water can flow from the water in the water container, through the tube, through the mouthpiece, and to the user. The obstruction can take the form of a threshold valve in the tube, a sized orifice in the immersed end of the tube, or a wad of cellulosic material in the tube.
-
公开(公告)号:US20210041518A1
公开(公告)日:2021-02-11
申请号:US16976028
申请日:2019-02-26
Inventor: Darin OKUDA
Abstract: Methods, apparatuses, systems, and implementations for creating 3-dimensional (3D) representations exhibiting geometric and surface characteristics of post-contrast brain lesions are disclosed. 3D MRI images of the brain may be created and acquired. After administration of a contrast substance, brain lesions and other abnormalities may be identified and isolated from the 3D MRI images, with each lesion serving as a region of interest (ROI). 3D region of contrast enhancement images may be created from segmented 3D MRI images and different regions of contrast enhancement of the brain lesion may be depicted. Saved regions of contrast enhancement may be converted into stereolithography format, maximum intensity projection (MIP) images, and/or orthographic projection images. Data corresponding to these resulting 3D region of contrast enhancement images may be used to create 3D printed models of the isolated region of contrast enhancement using 3D printing technology. Analysis of the 3D brain region of contrast enhancement images and the 3D printed region of contrast enhancement models may enable a more efficient an accurate way of determining brain lesion risk factors and effective treatment regimes.
-
公开(公告)号:US20210030680A1
公开(公告)日:2021-02-04
申请号:US15733741
申请日:2019-04-15
Inventor: Raushan T. KURMASHEVA , Kytai T. NGUYEN
IPC: A61K9/14 , A61P35/00 , A61K9/00 , A61K31/5025
Abstract: Described herein are methods of treatment of cancer by administering a therapeutically effective amount of a cytotoxic alkylating agent and a nanoparticle formulation containing an inhibitor of poly (ADP-ribose) polymerase 1. Also disclosed are treatment regimens involving parenteral administration of a therapeutically effective amount of a cytotoxic alkylating agent and a nanoparticle formulation containing an inhibitor of poly (ADP-ribose) polymerase 1.
-
-
-
-
-
-
-
-
-